Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

National Healthcare Properties (HLTC) EBITDA Margin (2016 - 2025)

Historic EBITDA Margin for National Healthcare Properties (HLTC) over the last 13 years, with Q3 2025 value amounting to 20.65%.

  • National Healthcare Properties' EBITDA Margin rose 404200.0% to 20.65% in Q3 2025 from the same period last year, while for Sep 2025 it was 20.91%, marking a year-over-year increase of 449400.0%. This contributed to the annual value of 59.45% for FY2024, which is 306700.0% down from last year.
  • National Healthcare Properties' EBITDA Margin amounted to 20.65% in Q3 2025, which was up 404200.0% from 30.93% recorded in Q2 2025.
  • In the past 5 years, National Healthcare Properties' EBITDA Margin registered a high of 4.33% during Q1 2021, and its lowest value of 136.45% during Q2 2024.
  • Moreover, its 5-year median value for EBITDA Margin was 20.65% (2025), whereas its average is 28.82%.
  • Its EBITDA Margin has fluctuated over the past 5 years, first plummeted by -1186900bps in 2024, then soared by 1055200bps in 2025.
  • Quarter analysis of 5 years shows National Healthcare Properties' EBITDA Margin stood at 17.66% in 2021, then plummeted by -62bps to 28.57% in 2022, then tumbled by -62bps to 46.26% in 2023, then skyrocketed by 55bps to 20.63% in 2024, then decreased by 0bps to 20.65% in 2025.
  • Its EBITDA Margin stands at 20.65% for Q3 2025, versus 30.93% for Q2 2025 and 11.58% for Q1 2025.